This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on April 3, 2023.

Return to the list of Patented Medicine Litigation page.

---

---

Abiraterone

ZYTIGA – Janssen Inc. (NOC Search)

Patents:

• 2661422: REDDY, PHARMASCIENCE, , SANDOZ, JAMP, APOTEX, TEVA
• 2661442: PHARMASCIENCE, REDDY

Unknown/Other

• PM(NOC) – T-1285-20
• Correction of Patent Office Records – T-1495-17

APOTEX

• PM(NOC) – A-267-20 (2022 FCA 185) – A-38-21 – A-437-19 (2021 FCA 45) – T-1661-17 (2019 FC 1355) – T-84-19 (2021 FC 3)
• Section 8 – T-607-21 (2022 FC 1477)
• Other – 19-A-20

JAMP

• PM(NOC) – T-989-20

PHARMASCIENCE

• Appeal – A-36-21 (2022 FCA 184)
• Section 8 – T-732-22
• PM(NOC) – T-182-19 (2021 FC 5, 2021 FC 7) – T-1893-19 (2021 FC 6)

REDDY

• Section 8 – T-1168-21 (2022 FC 1473, 2022 FC 1672, 2023 FC 216, 2023 FC 448)
• PM(NOC) – T-978-19 (2021 FC 4)
• Appeal – A-37-21

SANDOZ

• PM(NOC) – T-181-19

TEVA

• PM(NOC) – T-1503-17 – T-1504-17

---

Return to the Patented Medicine Litigation page.